RAPAMUNE 2 mg (Rapamune 2 mg)
Generic Name: sirolimus
Pill with imprint RAPAMUNE 2 mg is Beige, Three-sided and has been identified as Rapamune 2 mg. It is supplied by Wyeth-Ayerst Laboratories.
Rapamune is used in the treatment of lymphangioleiomyomatosis; organ transplant, rejection prophylaxis and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Rapamune 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RAPAMUNE 2 mg
Rapamune
- Generic Name
- sirolimus
- Imprint
- RAPAMUNE 2 mg
- Strength
- 2 mg
- Color
- Beige
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- MTOR inhibitors, Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Wyeth-Ayerst Laboratories
- National Drug Code (NDC)
- 00008-1032
Related Images for "RAPAMUNE 2 mg"
More about Rapamune (sirolimus)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- Generic Availability
- Drug class: mTOR inhibitors
- FDA Alerts (5)
Consumer resources
- Rapamune
- Rapamune (Sirolimus Oral Solution)
- Rapamune (Sirolimus Tablets)
- Rapamune (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
